Published in Vaccine Weekly, June 24th, 1996
Ultraviolet light research at the Wellesley Central Hospital and Toronto Hospital, Western Division, have been chosen to help determine whether RA remission may be triggered by this novel therapy.
Dr. Edward Keystone, Arthritis Society, is confident about the prospects for success of his trials of extracorporeal photochemotherapy, considering a similar concept is already used effectively to aid people with psoriasis. Keystone's optimism is also fueled by the success rate of an earlier, uncontrolled study of photochemotherapy with a small...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.